3-iodobenzylguanidine has been researched along with histamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hancock, JP; Kemshead, JT; Lashford, LS | 1 |
| Halldórsson, H; Jónsson, O; Kjeld, M; Thorgeirsson, G | 1 |
2 other study(ies) available for 3-iodobenzylguanidine and histamine
| Article | Year |
|---|---|
Meta-iodobenzylguanidine (mIBG) uptake and storage in the human neuroblastoma cell line SK-N-BE(2C).
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Binding, Competitive; Biological Transport, Active; Cell Line; Desipramine; Dopamine; Dose-Response Relationship, Drug; Histamine; Humans; In Vitro Techniques; Iodobenzenes; Neuroblastoma; Norepinephrine; Serotonin; Tyramine | 1991 |
Inhibitory effects of meta-iodo-benzylguanidine (MIBG) on endothelial histamine receptor binding.
Topics: 3-Iodobenzylguanidine; Binding, Competitive; Cells, Cultured; Choline; Cyclic GMP; Cytidine; Endothelium, Vascular; Histamine; Histamine H1 Antagonists; Humans; Inositol; Iodobenzenes; Nitric Oxide; Phospholipids; Propranolol; Pyrilamine; Receptors, Histamine H1; Serine; Umbilical Veins | 1998 |